Fibrinogen A alpha 12 and B beta 448 polymorphisms are not related to bleeding during oral vitamin K-antagonist treatment

Andrea A. Garcia, Niels V. van der Hoeven, Thierry N. Boellaard, JF van der Heijden, Angelique P. A. Groot, Pieter H. Reitsma*

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)676-678
Number of pages3
JournalThrombosis and Haemostasis
Volume97
Issue number4
DOIs
Publication statusPublished - Apr 2007

Keywords

  • THR312ALA POLYMORPHISM
  • RISK

Cite this